The structural basis of the quaternary organization of rhodopsin has recently been explored and modeled. Because information obtained from studying rhodopsin has frequently been directly applicable to other G protein-coupled receptors we wished to ascertain if dimeric and/or oligomeric forms of the 1b -adrenoceptor could be observed and if so whether rhodopsin might provide insights into the quaternary structure of this receptor. Co-immunoprecipitation and both conventional and time-resolved Xuorescence resonance energy transfer studies demonstrated quaternary structure of the 1b -adrenoceptor and, in concert with the reconstitution of fragments of this receptor, provided information on the molecular basis of these interactions. Development of three color Xuorescence resonance energy transfer (FRET) allowed the imaging of 1b -adrenoceptor oligomers in single living cells. Mutation of hydrophobic residues in transmembrane domains I and IV of the receptor resulted in marked reduction in three color FRET suggesting an alteration in oligomeric organization and potential similarities with rhodopsin. The mutated 1b -adrenoceptor was unable to reach the cell surface, did not become terminally N-glycosylated and was unable to signal.
Introduction
Recent evidence has indicated that most G proteincoupled receptors (GPCRs) 1 do not generally exist as monomers but rather as dimers or, potentially, within higher-order oligomers (Milligan, 2004a) . Support for such models has been provided by a range of studies employing diVerent approaches, including co-operativity of ligand binding, co-immunoprecipitation of co-expressed but diVerentially epitope-tagged forms of the same GPCR and a variety of resonance energy transfer techniques (Milligan & Bouvier, 2005; PXeger & Eidne, 2006) . However, only for a few GPCRs has information on the molecular basis of quaternary interactions become available and only for rhodopsin has the organizational structure of a GPCR been imaged in situ. Because many aspects of the function and structure of rhodopsin have proved to have direct parallels in other GPCRs, this information has impacted on our studies on the 1b -adrenoceptor.
The structural organization of rhodopsin
High resolution, three-dimensional crystal structures of a GPCR are only available for rhodopsin (Li, Edwards, Burghammer, Villa, & Schertler, 2004; Palczewski et al., 2000) . However, these static structures of detergent-extracted receptor, although remarkably informative on the orientation and organization of the seven transmembrane helix bundle, provided no insights into potential quaternary structure. By contrast, both the application of atomic force microscopy to discs from mouse rod outer segments (Liang et al., 2003) and the use of cryo-electron microscopy on two-dimensional crystals of squid rhodopsin (Davies, Gowen, Krebs, Schertler, & Saibil, 2001 ) have shown higher-order organization of the protein. In the pictures obtained by atomic force microscopy, rhodopsin is organized within para-crystalline arrays with densely packed, double rows of the receptor. Using such images as a starting point, and given the high density of rhodopsin in rod outer segments, models of potential quaternary structure were generated that optimized packing arrangements. These models suggested interactions between rows of dimers to be provided by contacts between elements of transmembrane domain I, whilst key interactions between monomers of a dimer appear to be provided by contacts involving transmembrane domains IV and V (Fotiadis et al., 2004) . Interestingly, the electron density maps derived from the twodimensional crystals of squid rhodopsin provide evidence of a symmetrical transmembrane domain IV-transmembrane domain IV interaction as a key structural interface (Davies et al., 2001 ) and although squid rhodopsin has relatively low overall sequence identity with mammalian opsins this may well represent a conserved element in interactions between rhodopsin-like, family A GPCRs. As an alternative approach to explore the basis of protein-protein interactions, opsin was recently expressed heterologously in COS1 cells (Kota, Reeves, Rajbhandary, & Khorana, 2006) . Following initial Xuorescence resonance energy transfer (FRET) experiments to conWrm interactions between forms of opsin tagged with either cyan or yellow Xuorescent protein, dimer formation was assessed by the rate of disulphide bond formation in the presence of cupric ortho-phenanthroline, using opsin mutants in which a range of speciWc amino acids were mutated to cysteine. These studies showed most rapid dimer formation with the mutants W 175 C (transmembrane domain IV) and Y 206 C (transmembrane domain V) (Kota et al., 2006) consistent with key roles of these regions in quaternary structure. Of course, the rod outer segment is a highly specialized structure in which rhodopsin comprises close to 50% of the total protein. By contrast, many GPCRs in other tissues are expressed in relatively small amounts. It is therefore unclear if the in situ oligomeric organization of rhodopsin is relevant to other GPCRs or to other environments. Recently, however, molecules of rhodopsin reconstituted into asolectin liposomes were shown to self-associate into dimers or multimers (Mansoor, Palczewski, & Farrens, 2006) and this provided evidence that rhodopsin can spontaneously self-associate in membranes other than the rod outer segment (Mansoor et al., 2006) . Furthermore, recent studies on the molecular basis of dimerization of the dopamine D2 receptor has provided clear evidence for a key role of transmembrane domain IV (Guo, Shi, & Javitch, 2003; Guo, Shi, Filizola, Weinstein, & Javitch, 2005) .
The 1 -adrenoceptors
The 1 -adrenoceptor family in man and other mammals is derived from three related genes. These encode the 1a -, 1b -and 1d -adrenoceptor subtypes (Piascik & Perez, 2001) . Although ligands with substantial discrimination between the subtypes have been relatively slow to emerge, recent advances in this area, combined with gene knockout technologies, have indicated overlap of distribution and key functions of these GPCRs in regulating vascular tone and hypertrophic growth of smooth muscle and cardiac cells (Koshimizu, Tanoue, Hirasawa, Yamauchi, & Tsujimoto, 2003) .
1b -Adrenoceptor dimerization: Initial studies
Initial studies on the structural organization of the 1b -adrenoceptor used co-immunoprecipitation of diVerently epitope-tagged forms of the receptor. Only when the two forms were co-expressed in heterologous cells and not when diVerent cell populations, each expressing one form of the receptor, were mixed prior to immunoprecipitation with antibody to one of the two epitope tags, was coimmunoprecipitation achieved (Carrillo, Pediani, & Milligan, 2003; Stanasila, Perez, Vogel, & Cotecchia, 2003; Uberti, Hall, & Minneman, 2003) . In each of these cases, following SDS-PAGE of the immunoprecipitated samples and immunoblotting to detect the tag not used for immunoprecipitation, a series of bands were detected. The polypeptide with highest mobility corresponded to the expected size for an 1b -adrenoceptor monomer. Bands with lesser mobility were approximately twice the size of the monomer, whilst a further, less well deWned group of immunoreactive bands entered the gels poorly. Although there may be exceptions (Zeng & Wess, 1999) , interactions between rhodopsin-family GPCRs are not generally anticipated to involve covalent links. It thus remains possible that the polypeptides with apparent high molecular mass are simply protein aggregates stemming from removal of the receptors from the membrane lipid environment. In the studies of Carrillo et al. (2003) and Stanasila et al. (2003) , further approaches were employed to support the co-immunoprecipitation data. Stanasila et al. (2003) C-terminally tagged the 1b -adrenoceptor with either cyan Xuorescent protein (CFP) or green Xuorescent protein (GFP) and employed FRET to demonstrate proximity and hence potential interactions when the two forms were co-expressed. They also demonstrated that additional expression of 1b -adrenoceptor not tagged with a Xuorescent protein reduced the FRET signal and that such a reduction in FRET signal was not produced by coexpressing the CCR5 chemokine receptor, a GPCR that is only distantly related to the 1b -adrenoceptor. Carrillo et al. (2003) employed a distinct FRET-based technique. Taking advantage of the N-terminal epitope tags introduced for the co-immunoprecipitation studies, they employed time-resolved FRET between anti-epitope tag antibodies labeled with appropriate energy donor and acceptor species and hence demonstrated interactions between successfully cell surface-delivered forms of the 1b -adrenoceptor in intact cells. Carrillo et al. (2003) also developed a functional complementation strategy. They had previously shown that a single open-reading frame fusion protein between the 1b -adrenoceptor and the subunit of the Ca 2+ mobilizing G protein G 11 was functional and could be used to measure agonist stimulated binding of [
35 S]GTP S (Carrillo, Stevens, & Milligan, 2002) . Now they demonstrated that the ability of the fusion protein to bind [
35 S]GTP S in an agonist-dependent manner could be eliminated by either a point mutation in the second intracellular loop of the receptor or by a point mutation in the G protein. When the two inactivated fusion proteins were co-expressed, agonist-mediated binding of [
35 S]GTP S was restored. Because this also occurred in cells that lack endogenous expression of any Ca 2+ mobilizing G proteins, it must have involved an inter-molecular interaction between the two inactive fusion proteins. Carrillo, Lopez-Gimenez, and Milligan (2004) subsequently conWrmed the capacity of C-terminally CFP and yellow Xuorescent protein (YFP)-tagged forms of the 1b -adrenoceptor to generate FRET signals following co-expression.
How does the 1b -adrenoceptor dimerize?
As a Wrst approach to this question Stanasila et al. (2003) generated a series of mutated and modiWed forms of the receptor. Studies on the yeast factor receptor had identiWed a glycophorin A-like motif (GXXXG) in transmembrane helix I and shown that modiWcation of key amino acids of this motif resulted in a reduction in FRET consistent with abrogation of dimerization (Overton, Chinault, & Blumer, 2003) . Although the 1b -adrenoceptor has a similar motif in transmembrane helix I, the mutation Gly 53 Leu in this region did not reduce FRET signals (Stanasila et al., 2003) . Neither did an equivalent mutation of a second glycophorin A-like motif in transmembrane helix VI. A variety of studies had suggested roles for both the intracellular C-terminal tail and the glycosylation state of the extracellular N-terminal region in protein-protein interactions of other rhodopsin-like GPCRs (Milligan, 2004a) . However, neither truncation of the Cterminal tail nor mutation to prevent N-glycosylation reduced FRET signals of the 1b -adrenoceptor. Indeed, Cterminal truncation actually resulted in a higher FRET signal (Stanasila et al., 2003) . However, as FRET signals are dependent upon both distance between, and the relative orientation of, the FRET donor and acceptor (Milligan, 2004b) , interpretation of this observation is diYcult. Based on demonstration of an interaction between the full length 1b -adrenoceptor and a fragment comprising only the N-terminal extracellular domain and transmembrane domain I by time-resolved FRET, Carrillo et al. (2003 Carrillo et al. ( , 2004 ) adopted a systematic receptor fragment-interaction approach. This involved taking the extracellular N-terminus of the 1b -adrenoceptor and linking it to fragments of the receptor consisting of transmembrane domains, I, III, V or VII and, because of the anti-parallel arrangement of the intervening domains, transmembrane domains I + II, III + IV and V + VI that also incorporated the intracellular loops that link these pairs of transmembrane domains. Each of these constructs was then used in every possible combination for both co-immunoprecipitation and timeresolved FRET studies to identify interactions. Only transmembrane domain I and transmembrane domain IV displayed symmetrical interactions, i.e. they self-associated. These results were potentially consistent with the 1b -adrenoceptor forming dimers in two distinct ways, via transmembrane domain I-I interactions and via transmembrane domain IV-IV interactions (Fig. 1) . Interestingly, both of these regions have received support as dimerization interfaces in studies employing diVerent GPCRs (Milligan, 2005) . However, comparisons with the atomic force microscope images of the in situ organization of rhodopsin (Fotiadis et al., 2004; Liang et al., 2003) suggested the possibility of a more complex model. Viewed from the extracellular space, the transmembrane helices of GPCRs are organized in an anti-clockwise orientation. Transmembrane domain I-transmembrane domain I interactions between adjacent monomers leaves transmembrane domain IV available to form a IV-IV interaction which then leaves transmembrane domain I free to potentially generate a further interaction. This pattern could build up into a 'daisy-chain' of repeating dimers to generate an oligomer of undeWned size (Fig. 1) . Furthermore, the receptor fragment complementation studies also indicated a series of non-symmetrical interactions involving elements of transmembrane domains I and/or II with transmembrane domains V and/or VI and it was hypothesized that such interactions could allow rows of dimers to form (Carrillo et al., 2004) . Stanasila et al. (2003) had shown a lack of substantial FRET signal following co-expression of 1b -adrenoceptor-CFP and 2 -adrenoceptor-GFP, suggesting that these two closely related GPCRs do not interact. To identify transmembrane domains responsible for 1b -adrenoceptor self-interactions they thus generated forms of the 1b -adrenoceptor in which each transmembrane domain was systematically replaced with the corresponding sequence from the 2 -adrenoceptor. Statistically signiWcant decreases in FRET signal were reported only with replacement of transmembrane domain I and transmembrane domain VII. By contrast, FRET signals were absent when the full length 1b -adrenoceptor was co-expressed with fragments of the receptor that lacked the N-terminus and transmembrane domains I + II, although not when a fragment comprising the N-terminus and the sequence up to and including transmembrane domain III was co-expressed (Stanasila et al., 2003) . Thus, although these studies did not provide evidence for a key role of transmembrane domain IV, they did imply a role for transmembrane domain I. 
The 1b -adrenoceptor can form an oligomeric complex
Two component FRET cannot usefully discriminate between dimers and higher-order structures. Lopez-Gimenez, Canals, Pediani, and Milligan (2006) therefore developed and employed a sequential three color FRET imaging approach to gain support for oligomeric structures of the 1b -adrenoceptor in single living cells that might be similar to the observed organization of rhodopsin in rod outer segment discs. Initially, these studies employed a single openreading frame concatamer of CFP, YFP and DsRed2, as initially used by others (Galperin, Verkhusha, & Sorkin, 2004) to establish appropriate imaging conditions. Following transfection of this concatamer into HEK293 cells, Xuorescence corresponding to each of CFP, YFP and DsRed2 could be observed in single cells and with appropriate excitation, and the application of a novel FRET algorithm, each of CFP to YFP, YFP to DsRed2 and CFP to DsRed2 FRET could be measured in single cells. To prove that the CFP to DsRed2 FRET signal truly represented sequential CFP to YFP to DsRed2 energy transfer and not direct CFP to DsRed2 FRET, a second concatamer was employed. This was identical to the Wrst except it contained a Tyr 67 Cys mutation in the YFP element. This mutation ablates
Xuorescence of YFP and therefore Tyr 67 Cys YFP can act as neither a resonance energy transfer donor nor acceptor. CFP to DsRed2 FRET was abolished, conWrming the CFP to DsRed2 FRET produced from the initial concatamer represented sequential CFP to YFP to DsRed2 FRET and not direct CFP to DsRed2 FRET (Fig. 2) .
With this information in place, forms of the 1b -adrenoceptor C-terminally tagged with each of CFP, YFP and DsRed2 were co-expressed in HEK293 cells and produced CFP to DsRed2 FRET. Such observations are consistent with at least a proportion of the 1b -adrenoceptor existing in an oligomeric complex (Lopez-Gimenez et al., 2006) . By contrast, simple co-expression of each of CFP, YFP and DsRed2 produced no such FRET signal. Equally co-expression of 1b -adrenoceptor-CFP, 1b -adrenoceptorTyr 67 CysYFP and 1b -adrenoceptor-DsRed2 failed to generate CFP to DsRed2 FRET (Lopez-Gimenez et al., 2006) .
Disruption of eVective oligomerization prevents cell surface delivery of the 1b -adrenoceptor
To explore the role of transmembrane domains I and IV in oligomerization, pairs of adjacent, hydrophobic residues in these regions (Fig. 3) were mutated to alanines and three Fig. 3 . Mutations introduced into the 1b -adrenoceptor to attempt to modulate oligomeric organization. The 1b -adrenoceptor is displayed in a ribbon diagram as a monomeric polypeptide. Based, in part, on the bio-informatic analysis of (de Juan et al., 2005) hydrophobic amino acids at the locations noted in transmembrane domains I and IV were mutated to alanines. These amino acids are coded using the nomenclature of Ballesteros and Weinstein that relates positions in the transmembrane domains to the location of the most conserved residue in that helix. 
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color FRET studies performed. The mutations resulted in reduced sequential three color FRET consistent with alterations in the oligomeric interactions and organization of the receptor (Lopez-Gimenez et al., 2006) . The functional consequences of this were also explored. Immunocytochemistry to detect an N-terminal epitope tag demonstrated wild type 1b -adrenoceptor at the cell surface. However, cell surface expression of the mutant 1b -adrenoceptor could not be detected although, following cell permeabilization, it was clear that the mutant was expressed as eVectively as the wild type receptor. Good expression of the mutated form could also be shown by simply monitoring Xuorescence of cells expressing C-terminally YFP-tagged forms of the wild type and mutated 1b -adrenoceptor (Lopez-Gimenez et al., 2006) .
Following transfection into a range of cell types (Morris, Price, Smith, Lei, & Schwinn, 2004; Pediani et al., 2005) and in physiological settings (Mackenzie, Daly, Pediani, & McGrath, 2000) wild type 1 -adrenoceptors recycle between the cell surface and endosomal compartments in a constitutive, agonist-independent manner. This can be shown using an anti-epitope tagged antibody labeled with the pH-sensitive dye CypHer-5 if the receptor is appropriately N-terminally tagged (Adie et al., 2003) . CypHer-5 displays red Xuorescence only when in an acidic environment, such as an endosome, and addition of the labeled antibody to cells expressing a suitably tagged 1b -adrenoceptor resulted in the development of red Xuorescence without addition of an agonist ligand. This is consistent with the receptor moving from the cell surface into an endosomal pool in a ligand-independent manner. By contrast, for many other GPCRs, including the orexin-1 receptor, this only occurs in the presence of agonist (Milasta et al., 2005) . A number of other GPCRs, including the cannabinoid CB1 receptor (Leterrier, Bonnard, Carrel, Rossier, & Lenkei, 2004; Leterrier et al., 2006) , share the characteristic of spontaneous internalization with 1 -adrenoceptors. Whilst addition of receptor antagonists restricts the spontaneous recycling of most of these GPCRs, this is not so for the 1 -adrenoceptors. Indeed, 1 -adrenoceptors are able to bind cell-impermeable antagonists whilst at the cell surface and carry these into the cell as the receptor cycles. BODIPY-labeled variants of antagonists related to the prototypic 1 -adrenoceptor blocker prazosin display Xuorescence only when bound to the receptor (Pediani et al., 2005) . They can therefore be used to monitor whether an 1 -adrenoceptor had previously been at the cell surface. When a BODIPY-labeled antagonist, that displays red Xuorescence when bound to receptor, was added to cells expressing a C-terminally YFP-tagged form of the 1b -adrenoceptor, the cells developed red Xuorescence in punctuate intracellular vesicles (Fig. 4) . Pixel by pixel analysis demonstrated strong yellow/red color overlap (Fig. 4) , indicating that the antagonist remained associated with the receptor inside the cell. This was not observed in cells expressing the mutated Fig. 4 1b -adrenoceptor, indicating again that the mutated receptor had not been delivered to the plasma membrane (Fig. 4) .
To explore a possible basis for the lack of cell surface delivery of the mutated 1b -adrenoceptor, studies were performed to examine receptor N-glycosylation. Although the wild type receptor was present as both apparent 75 and 105 kDa polypeptides, no 105 kDa form of the mutant was observed. De-glycosylation studies demonstrated the 105 kDa form of the wild type receptor to represent the mature form of the protein. Following treatment with N-glycosidase F this band was absent and the wild type receptor now migrated with apparent M r close to 70 kDa (LopezGimenez et al., 2006) . The mutant receptor thus appeared to be unable to become terminally N-glycosylated. An inability to be terminally N-glycosylated often is associated with poor plasma membrane delivery and traYcking of mutants of a range of GPCRs which are then sent to the proteasome for destruction (Petaja-Repo et al., 2001) .
The mutated 1b -adrenoceptor is unable to signal
As the mutated 1b -adrenoceptor appeared unable to reach the cell surface then it was expected to be unable to signal in response to agonist ligands. This was conWrmed in HEK293 cells expressing either the wild type 1b -adrenoceptor, C-terminally tagged with YFP or the mutant receptor C-terminally tagged with CFP. Such cells were grown on the same cover slip, loaded with the ratiometric Ca 2+ indicator dye FURA-2 and exposed to the 1 -adrenoceptor agonist phenylephrine. Increases in intracellular Ca 2+ were only observed in cells expressing the wild type receptor (Lopez-Gimenez et al., 2006) . This was not a reXection that cells expressing the mutated 1b -adrenoceptor were unable to respond to receptor ligands. Subsequent to washout of the 1 -adrenoceptor agonist, ATP was added to activate P 2 Y purinoceptors that are expressed endogenously by HEK293 cells. Equivalent increases in intracellular Ca 2+ were now observed in all cells.
Conclusions
As with many aspects of GPCR structure, function and regulation, understanding of the structural organization of rhodopsin in rod outer segments has greatly inXuenced ideas about other members of the rhodopsin-like GPCR family. Although a range of studies have indicated that the 1b -adrenoceptor possesses quaternary structure, it had been unclear if this was restricted solely to the formation of dimers or whether higher-order complexes might exist. Application of sequential three color FRET imaging in concert with fragment complementation approaches have help to deWne protein-protein interaction interfaces for the 1b -adrenoceptor and indicate similarities in overall organization with rhodopsin. However, these studies have relied on heterologous expression of the 1b -adrenoceptor and it will be important to develop means to assess if 1b -adrenoceptor oligomerization can also be observed in native tissues. It remains to be established whether oligomerization will be a general feature of other family A GPCRs and whether the molecular contacts involved will also be highly conserved. Although it appears that rhodopsin may retain function when limited to be a monomer, one role for oligomerization of the 1b -adrenoceptor appears to be to ensure cell surface delivery and hence a means to bind and response to circulating norepinephrine and epinephrine.
